Background: Postoperative infections have been a major issue in lung cancer surgery. We changed our perioperative prophylactic antibiotic policy to a single dose of cefazolin before and after surgery in July 2002. Objective: To identify the risk factors of postoperative pneumonia and empyema in lung cancer patients undergoing surgical resection. Methods: From July 1992 through September 2003, 2105 patients underwent primary lung cancer resection at our division. We reviewed 1855 eligible patients for possible risk factors of pneumonia and empyema. Results: Postoperative respiratory infections developed in 69 (3.7%) patients. There were 58 (3.1%) pneumonia cases and 18 (1.0%) cases of empyema. The mortality rate was 0.8% (15 patients). Nine (0.5%) patients died from postoperative respiratory infections. Multivariate analysis showed age 75 years or older, forced expiratory volume in 1 second as a percentage of forced vital capacity (FEV 1 %) less than 70%, advanced pathologic stage, and induction therapy to be independent risk factors of pneumonia. For postoperative empyema, advanced age was the significant factor. Twelve of 18 patients (67%) with empyema were complicated with bronchopleural fistula. The infection incidence rate did not change significantly after we modified our prophylactic antibiotic policy to a single dose of cefazolin before and after surgery. Conclusions: Lung cancer patients with advanced age, low FEV 1 %, advanced pathologic stage, or induction therapy had a risk for pneumonia after lung cancer surgery. Postoperative empyema was associated with advanced age.
P
ostoperative respiratory infection is a major issue in lung cancer surgery. Sok et al. 1 reported that 34 of 194 patients (18%) suffered from respiratory infections. The rates of pneumonia after pulmonary resection have been reported to range from 5.3% 2 to 22%. 3 Empyema is an intractable complication and can lead to a long hospital stay. Duque et al. 2 reported that 27 of 605 patients (4.4%) developed postoperative empyema after lung cancer surgery, and Belda et al. 4 reported an empyema rate of 6%.
Previous studies have shown smoking, 3, 5, 6 comorbid chronic obstructive pulmonary disease, 6, 7 advanced age, 8 diabetes mellitus (DM), 9 and obesity 6 to be associated with postoperative infections. The aim of this study was to identify the risk factors of postoperative pneumonia and empyema and to ascertain the efficacy of a single dose of prophylactic antibiotics prophylaxis. We retrospectively reviewed patients who underwent surgical resection for lung cancer and identified risk factors by univariate and multivariate analyses. To our knowledge, there have been no reports evaluating the risk factors associated with postoperative respiratory infections after lung cancer surgery on a large scale by multivariate analysis.
PATIENTS AND METHODS
From July 1992 through September 2003, 2105 consecutive patients underwent surgical resection for primary lung cancer at the Division of Thoracic Surgery, National Cancer Center Hospital East, Chiba, Japan. Retrospective data collection from their medical records and analyses were approved, and the need for informed consent from each patient was waived by the institutional review board in January 2005. Patients who underwent complete lung cancer resection and had complete perioperative data were enrolled, and 1855 were eligible. Their ages ranged from 22 to 90, with an average of 64 years. There were 1191 men and 664 women.
The surgical procedures were lobectomy in 1625 cases (87.6%), pneumonectomy in 100 (5.4%), wedge resection in 77 (4.2%), segmentectomy in 51 (2.7%), and bronchial resection in two (0.1%). We classified resection less than lobectomy as limited resection, and we classified combined resections with the chest wall, pericardium, great vessels, left atrium, vertebral bodies, or diaphragm as extended resection.
Cancers were pathologically staged according to the TNM classification system of the International Union Against Cancer staging system. 10 The pathological stages were as follows: 724 (39.0%) were IA, 376 (20.3%) IB, 72 (3.9%) IIA, 218 (11.8%) IIB, 266 (14.3%) IIIA, 167 (9.0%) IIIB, 28 (1.5%) IV, and four patients (0.2%) were stage 0. Of 31 patients who underwent induction therapy, 22 patients re-ceived chemotherapy, eight received chemoradiotherapy, and one received radiotherapy.
We performed resection under general anesthesia with an epidural catheter for postoperative pain control. All patients received local skin disinfection with povidone iodine immediately before surgery. The thoracic cavity was lavaged with 3 liters of warm saline immediately before chest closure. The ribs, muscles, and subcutaneous tissue were closed using absorbable sutures. Skin incisions were closed with buried sutures and suture strips.
Patients received uniform pain control. Epidural analgesia was continued for the first few days. Oral nonsteroidal antiinflammatory drugs were also administered for pain control, starting on the first postoperative morning. There was no attempt to assess levels of pain control.
All patients received perioperative prophylactic antibiotics. Until June 2002, the antibiotic regimen was at the discretion of each attending surgeon, mostly the first-generation cephalosporin for a few days starting immediately before surgery. From July 2002, patients received a single dose of 1.0 g of cefazolin immediately before skin incision and the same dose at 3 hours after surgery. If signs of postoperative infection, such as fever, purulent sputum, or infiltrative changes on a chest roentgenogram developed, additional antibiotics were allowed.
We documented postoperative pneumonia and empyema as postoperative respiratory infections. Postoperative pneumonia was defined as purulent sputum and pulmonary infiltrative changes on postoperative chest roentgenogram or computed tomography. Empyema was defined as purulent effusion in the postoperative thoracic cavity. These postoperative infections were not always be accompanied by a fever, leukocytosis, and/or elevated serum C-reactive protein level. Bronchoscopically proven bronchial stump failure with persistent air leakage was defined as bronchopleural fistula.
We investigated the incidence of postoperative pneumonia and empyema and analyzed the association between infection development and the following factors: age (Ͻ75 or Ն75 yr), sex, smoking history (positive or negative), body mass index Ͻ25 or Ն25), DM (positive or negative), forced expiratory volume in 1 second as a percentage of forced vital capacity (FEV 1 %; Ͻ70 or Ն70%), surgical procedure (limited resection, lobectomy, or extended resection), induction therapy (positive or negative), and pathologic stage (I/II or III/IV). Operative mortality was defined as a death from any cause during the postoperative hospital stay.
Statistical Analysis
In univariate and multivariate analyses, the logistic regression model was used to evaluate the risk factors associated with postoperative infections. The data were calculated using a StatView version 5 software package (SAS Institute Inc, Cary, NC). A p value of less than 0.05 was defined as indicative of statistical significance.
RESULTS
Postoperative respiratory infections developed in 69 (3.7%) of the 1855 patients. There were 58 (3.1%) pneumonia cases and 18 (1.0%) empyema cases. Seven (0.4%) patients developed both pneumonia and empyema. Eighteen of the 1855 patients (1.0%) developed bronchopleural fistula (BPF). Two of the 18 BPF patients underwent pneumonectomy. In the 18 empyema patients, 12 were complicated with BPF, and five were complicated with alveolar leakage or pneumonia. The mortality rate was 0.8% (15 patients). There were nine (0.5%) postoperative deaths from respiratory infections, and all of these patients were male smokers who had undergone a lobectomy. Of the 31 induction patients, seven (23%) underwent pneumonectomy, and 16 (52%) underwent extended resection. These rates were significantly higher (p Ͻ 0.001) than noninduction patients, indicating that induction patients had more advanced disease. Table 1 shows the relationships between postoperative infections and risk factors. More than 5% of the patients 75 years or older with FEV 1 % less than 70%, extended resection, induction therapy, or pathologic stage III/IV developed (Table 2) . In multivariate analyses, advanced age, low FEV 1 %, induction therapy, and pathologic stage were shown to be independent risk factors (Table 3) . For postoperative empyema, patients 75 years or older were at the highest risk (Table 1) . In univariate analyses, advanced age and male gender were the risk factors (Table 4) . Multivariate analysis showed that advanced age was a significant risk factor for empyema (Table 5) .
To investigate the relationships between perioperative prophylactic antibiotics therapy and postoperative infections, we compared the incidence of postoperative respiratory infections between the two phases before and after July 2002, when we changed our prophylactic antibiotics therapy at our hospital (Table 6 ). After we changed our perioperative prophylactic antibiotic policy, 76 of 321 patients (23.7%) required additional antibiotics. Fifty (3.3%) of 1534 patients developed pneumonia before July 2002, and eight (2.5%) of 321 patients developed pneumonia after July 2002. For empyema, there were 16 (1.0%) of 1534 and two (0.6%) of 262 patients before and after July 2002, respectively. Although there were no statistically significant differences between the two phases, the infection incidence rates reduced after we changed the perioperative antibiotic policy to a single dose of cefazolin before and after surgery.
DISCUSSION
In patients undergoing surgery for lung cancer, postoperative pneumonia and empyema strongly correlate with outcome and constitute a major issue in patient management. Nagasaki et al. 11 showed a mortality associated with postoperative pneumonia of 25%, and mortality associated with postoperative empyema was 22%. Because of hypoventilation, secretory retention, pain, and inefficient cough, lung cancer patients are at a high risk of developing atelectasis and pneumonia after surgery.
We found that age 75 years or older was an independent significant risk factor for postoperative pneumonia and empyema. Iwamoto et al. 8 investigated postoperative pneumonia and revealed that elderly patients older than 65 years who underwent thoracic surgery showed the highest incidence of pneumonia. Smoking, obesity, and DM have been reported to However, we could not find a significant correlation between postoperative pneumonia or empyema and these factors in multivariate analysis. Patients with chronic obstructive pulmonary disease were shown to be at a high risk of postoperative pneumonia. 6, 7 However, Cerfolio et al. 12 concluded that pulmonary complications were not associated with low FEV 1 . In the present report, multivariate analysis revealed a preoperative FEV 1 % of less than 70% was a significant risk factor for postoperative pneumonia. When low FEV 1 patients were 75 years or older, the risk of pneumonia was extremely high, at 10.7% (11/103; p Ͻ 0.0001). For these patients with impaired respiratory pulmonary function, preoperative rehabilitation might be needed to reduce the risk of postoperative respiratory complications. 13 Busch et al. 3 showed that extended resection involving either the chest wall or other adjacent structures was associated with pulmonary complications. They also reported a significant increase in major pulmonary complications in patients who had received induction chemotherapy. Martin et al. 14 reported that, among patients who received induction therapy, the incidence of pneumonia and empyema were 12.1 and 1.3%, respectively. Although our multivariate analysis did not show a correlation between the extent of surgical resection and postoperative pneumonia, patients who underwent induction therapy and those with advanced pathologic stage were shown to have a significant risk of postoperative pneumonia. The incidence of pneumonia after induction therapy was similar to the results of Martin et al., 14 at 13%. Induction therapy may be refrained in elderly patients.
Deschamps et al. 15 studied empyema after pneumonectomy and indicated that the risk of empyema was associated with lower preoperative FEV 1 , lower diffusion capacity of 16 Taghavi et al. 17 recently reported that bronchial stump coverage with a pedicled pericardial flap was highly effective in postpneumonectomy BPF prevention. In this study, no patients receiving induction therapy developed empyema or bronchopleural fistula. This might be attributable to the protective pedicled flap we used for these high-risk patients. Further prospective study is necessary to confirm the role of bronchial stump coverage with a pedicled flap, but a randomized study would be unfeasible because of the rarity of BPF. The Centers for Disease Control and Prevention recommended antimicrobial prophylaxis only when needed. 18 Ilves et al. 19 showed that prophylactic antibiotics were effective in reducing wound infections, but the incidence of pulmonary infections and empyema was not significantly decreased. Prolonged prophylactic antibiotics were reported not to be effective against postoperative pleuropulmonary infections. Olak et al. 20 revealed that six doses of cefazolin did not confer clinically important benefit beyond that obtained from a single dose as prophylaxis in elective general thoracic surgery. Our experience confirms these suggestions. A small dosage is also beneficial costwise.
In conclusion, we identified risk factors for postoperative respiratory infections in lung cancer patients. Elderly patients and patients after induction therapy need intensive perioperative management. Preoperative rehabilitation may be beneficial for those with impaired lung function.
